Skip to agency navigation
Skip to main content

Official website

of the Commonwealth of Pennsylvania

    The .gov means it's official.

    Local, state, and federal government websites often end in .gov. Commonwealth of Pennsylvania government websites and email systems use "pennsylvania.gov" or "pa.gov" at the end of the address. Before sharing sensitive or personal information, make sure you're on an official state website. 
    Councils & Committees

    ​Pharmacy and Therapeutics (P&T) Committee

    P&T Committee Meeting Information

    Upcoming Meetings

    Dates

    Locations

    • The September 2026 P&T Committee meetings will be held virtually.

    Public Testimony

    • All members of the public may register to provide verbal or written testimony related to a drug or class of drugs included on the Statewide PDL at the P&T Committee meetings.
    • Registration to present testimony during the meetings must be received by Wednesday, September 2, 2026. To register, please go to the Pennsylvania Medical Assistance Preferred Drug List website and select "Public Testimony Registration." Please include the drug or class of drugs you wish to speak on. You will receive a confirmation email for your public testimony registration, which will be separate from the email containing your webinar registration details.
    • Written testimony will be accepted and must be submitted by Wednesday, September 2, 2026. The written testimony will be distributed to all P&T Committee members prior to the meetings. Written testimony should be emailed to RA-PharmForms@pa.gov. You will receive a confirmation email that your written testimony has been received.

    Please check back for list of drug classes for review for upcoming meetings

    Related Links

    The Department of Human Services (Department) appointed the P&T Committee to act in an advisory capacity to the Department and the Office of Medical Assistance Programs (OMAP) and provide an unbiased clinical perspective on the Department's Statewide Preferred Drug List (PDL). Recommendations from the committee must be reviewed and approved by the Secretary of the Department of Human Services.

    OptumRx, Inc provides clinical and financial analysis support to the P&T Committee.

    Committee Information

    Composition and responsibilities of the committee:

    • Comprised of department medical directors, external physicians, pharmacists, consumer advocates, and specialists as needed for drug class reviews.
    • Recommend a clinically-based PDL with an emphasis on effectiveness, safety, and outcomes.
    • Recommend prior authorization guidelines for non-preferred drugs as well as certain preferred drugs using current community standards for prescribing.
    • Recommend Prospective and Retrospective Drug Utilization Review Program Review and Development.

     

    Name

    Specialty

    Independent*

    Department**

    MCO

    Ivonne Acrich, MD

    OMHSAS Child/Adolescent Psychiatrist

     

    X

     

    Christopher Antypas, PharmD

    Community Pharmacist

    X

     

     

    Lawrence Appel, MD, SFHM

    Medical Director, Office of Long Term Living

     

    X

     

    Terri Cathers, PharmD,
    Chair (tie-breaker vote only)

    OMAP Pharmacy Director

     

    X

     

    Sharon Connor, PharmD

    Academic Pharmacist

    X

     

     

    ​Molly DiMatteo, DO

    ​Family Practitioner

    ​X

    ​

    ​

    ​Oluwatoyin Fadeyibi, PharmD, MPH

    ​Community Behavioral Health Pharmacist

    ​

    ​

    ​X

    Andrea Fox, MD

    Internist

    X

     

     

    Mark Fuller, MD

    		Carelon Health of PA Medical Director      X

    Donald Gerhart, RPh

    Community Pharmacist

    X

     

     

    Julie Graziane, MDOMHSAS Medical Director X 

    James Hancovsky, RPh, MBA

    United Health Care Pharmacy Director

     

     

    X

    Van Hellerslia, PharmD, BCPSConsumer RepresentativeX  

    ​David Kelley, MD

    ​OMAP Chief Medical Officer, Office of Medical Assistance Programs

    ​

    ​X

    ​

    Chen Kenyon, MD, MSHPPediatricianX  

    Peter Kreckel, RPh

    Community Pharmacist

    X

     

     

    Renee Licwinko, RPh

    Highmark Wholecare Pharmacist

     

     

    X

    Michele Musheno, RPh, MS

    Academic/Hospital Pharmacist

    X

     

     

    ​Geoffrey Neimark, MD

    ​Community Care Behavioral Health Psychiatrist

    ​

    ​

    ​X

    Ian Paul, MD, Vice Chair

    Pediatrician

    X

     

     

    Mike Pelyhes, PharmD AmeriHealth Caritas & Keystone First HealthChoices & Community HealthChoices Pharmacist  ​X

    Adam Raphael Rom, MD

    Family Practitioner

    X

     

     

    Amy Saracino, DO

    OMHSAS Adult Psychiatrist

     

    X

     

    John Shand, MDPerformCare PA Medical Director  X
    Jason Skaria, PharmDPA Health & Wellness Pharmacist  X

    ​Christopher Squillaro, DO

    ​Magellan Behavioral Health of PA Medical Director

    ​

    ​

    ​X

    Kevin Szczecina, RPh

    Geisinger Health Plan Pharmacist

     

     

    X

    ​Fallan Vaisberg, PharmD, RPh

    ​Health Partners Plans Formulary Pharmacist

    ​

    ​

    ​X

    Andreas Wali, MD

    ​Cardiologist

    ​X

    ​

    ​

    Verlyn Warrington, MD

    Bariatric Medicine Specialist/Family Medicine Doctor

    X

     

     

    Lloyd Wertz

    Consumer/Family Advocate

    X

     

     

    ​Lauren Zandier, PharmD

    ​UPMC For You Pharmacist

    ​

    ​

    ​X

    * - Independent Members are not employed by the Department
    ** - Department Members are employed by the Department on a full or part-time basis

    Effective December 22, 2025 / Last modified May 12, 2026